Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer
Ali Alhuseinalkhudhur(Uppsala University), Jens Nørkær Sørensen(Technical University of Denmark), Joachim Feldwisch(Uppsala University), Henrik Lindman(Uppsala University), Mark Lubberink(Uppsala University), Irina Velikyan(Uppsala University), Vladimir Tolmachev(Uppsala University), Fredrik Y. Frejd(Uppsala University)
Cited by 25
Related Papers
Cardiovascular Effects of Treatment With the Ketone Body 3-Hydroxybutyrate in Chronic Heart Failure Patients
|Circulation|2019|513
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
|PLoS ONE|2009|504
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial
|The Lancet|2000|343
Quantitative Assessment of Myocardial Perfusion in the Detection of Significant Coronary Artery Disease
|Journal of the American College of Cardiology|2014|324